Pneumatic Compression Vs Blood Flow Restriction for Muscle Recovery

Not Applicable

Recruiting

• Conditions: Delayed Onset Muscle Soreness

• Registration Number: NCT06815367
• Lead Sponsor: University of Southern California

Brief Summary

Both BFR and intermittent pneumatic compression are purported to decrease symptoms associated with exercise induced muscle damage (EIMD) that cause delayed onset muscle soreness (DOMS). Blood flow restriction relies on applying pressurized cuffs to the most proximal portion of the limb. Another form of recovery often relied upon is pneumatic compression. The mechanism by which pneumatic compression works is similar to that of a massage, whereby the device progressively increases the pressure on a portion of the limb before releasing and moving further up the limb.The purpose of this study is determine whether BFR or pneumatic compression can be used to decreased DOMS which may indicate enhanced recovery.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-01-15
• Study First Submitted: 2024-09-17
• Status Verified: 2025-02
• Study First Submitted QC: 2025-02-05
• Last Update Submitted: 2025-02-05
• Study First Posted: 2025-02-07
• Last Update Posted: 2025-02-07
• Primary Completion: 2025-07-01
• Study Completion: 2025-07-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

• 18-30 years of age
• Recreationally active population
• Women should be on a form of hormonal contraception.
• No current musculoskeletal injuries or pathologies
• Must answer "yes" to all PAR-Q questions.

Exclusion Criteria

• Individuals that routinely train trail running
• Discomfort when running
• Deep vein thrombosis
• Blood clots
• Cancerous lesions
• Sensory or mental impairment
• Unstable fractures
• Acute pulmonary edema
• Acute thrombophlebitis
• Acute congestive cardiac failure
• Acute infections
• Episodes of pulmonary embolism
• Wounds, lesions, infection, or tumors
• Bone fractures or dislocations
• Increased venous and lymphatic return
• Answers "no" to any of the PAR-Q screening questions

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Counter Movement Jump Height	Immediately before and immediately after exercise, immediately after treatment, 24-hours post treatment.	Participants will be asked to complete three consecutive counter movement jumps with hands on hips. The CMJ will be used as an indirect measure of muscle function.
Maximal Voluntary Isometric Contraction	Immediately before and immediately after exercise, immediately after treatment, 24-hours post treatment.	Participants will be asked to complete an MVIC to assess muscle function.
Sedentary delayed onset muscle soreness	Immediately before and immediately after exercise, immediately after treatment, 24-hours post treatment.	Using a visual analog scale, participants will be asked to rate their level of soreness while at rest.
Active delayed onset muscle soreness	Using a visual analog scale, participants will be asked to rate their level of soreness while at rest.	Using a visual analog scale, participants will be asked to rate their level of soreness while completing a wall sit.

Trial Locations

Locations (1)

University of Southern California; 🇺🇸 Los Angeles, California, United States